Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Edelman Financial Services

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$6M
Portfolio companies 2
Rounds per year 0.06
Lead investments 1
Exits 1
Key employees Soon

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Electronics
  • Water
  • Power Grid
Summary

In 1986 was created Edelman Financial Services, which is appeared as Corporate Investor. The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the Houston.

The standard case for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are British Columbia Discovery Fund, Altira Group. In the next rounds fund is usually obtained by Redpoint, Connecticut Innovations.

The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2005. The usual things for fund are deals in the range of 5 - 10 millions dollars.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Customer Service. Among the most popular portfolio startups of the fund, we may highlight BioPro Pharmaceutical.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Broadband Venture Partners Dallas, Texas, United States
Cadence Bancorp Houston, Texas, United States
Catchlight Ventures New York, New York, United States
Changying Technology China, Guangdong Province, Maoming City
Fluxus Ventures France, Ile-de-France, Paris
Invicta Angels Brazil, Rio Grande do Sul, Viamão
IRDI France, Occitania, Toulouse
Kaplan Florida, Fort Lauderdale, United States
Logitech Investments -
Manatt Venture Fund California, Los Angeles, United States
MCB Salt -
Mendes -
Ministry of Business, Innovation and Employment New Zealand, Wellington, Wellington
Naos -
Octave Life Sciences -
Sumitomo Electric Japan, Osaka, Osaka Prefecture
Superangel Estonia, Harjumaa, Tallinn
the Entrepreneur Fund. -
Woori Bank Seoul, Seoul-t'ukpyolsi, South Korea
Youguang Network China, Shanghai, Xuhui

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

BioPro Pharmaceutical

Biotechnology
Pharmaceutical
$5M18 Oct 2005 San Francisco, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Edelman Financial Services?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 6M
Rounds per year 0.06
Peak activity year 2005
Lead investments 1
Exits 1
Group Appearance index 0.50

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

BioPro Pharmaceutical

Biotechnology
Pharmaceutical
$5M18 Oct 2005 San Francisco, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: